Georgia L. Erbez's most recent trade in Codexis Inc. was a trade of 3,826 Common Stock done at an average price of $1.3 . Disclosure was reported to the exchange on Feb. 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Codexis Inc | Georgia L. Erbez | See Remarks | Sale of securities on an exchange or to another person at price $ 1.31 per share. | 06 Feb 2026 | 3,826 | 66,810 (0%) | 0% | 1.3 | 5,001 | Common Stock |
| Codexis Inc | Georgia L. Erbez | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.51 per share. | 13 Oct 2025 | 6,239 | 70,636 (0%) | 0% | 2.5 | 15,629 | Common Stock |
| Coherus Biosciences Inc | Georgia L. Erbez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 112,000 | 112,000 | - | - | Stock Option (Right to Buy) | |
| Codexis Inc | Georgia L. Erbez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 161,250 | 161,250 | - | - | Stock Option (Right to Buy) | |
| Codexis Inc | Georgia L. Erbez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 26,875 | 76,875 (0%) | 0% | 0 | Common Stock | |
| Codexis Inc | Georgia L. Erbez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2024 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Codexis Inc | Georgia L. Erbez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2024 | 50,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
| Coherus Biosciences Inc | Georgia L. Erbez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 114,000 | 114,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Georgia L. Erbez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 54,000 | 54,000 | - | - | Stock Option (Right to Buy) | |
| Harpoon Therapeutics Inc | Georgia L. Erbez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 115,000 | 115,000 | - | - | Employee Stock Option (right to buy) | |
| Harpoon Therapeutics Inc | Georgia L. Erbez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 115,000 | 115,000 | - | - | Employee Stock Option (right to buy) | |
| Harpoon Therapeutics Inc | Georgia L. Erbez | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 8.10 per share. | 22 Sep 2021 | 10,300 | 19,215 (0%) | 0% | 8.1 | 83,430 | Common Stock |